Newsfeeds - Spark Newswire

1 minute read

ANI Pharmaceuticals Q2 Adj. EPS $0.67 Misses $0.68 Estimate, Sales $48.60M Beat $48.05M Estimate

Today, 10:44 PM

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $0.67 per share which missed the analyst consensus estimate of $0.68 by 1.47 percent. This is a 2.9 percent decrease over earnings of $0.69 per share from

ANIP

6 minute read

Earnings Scheduled For August 6, 2021

By Benzinga Insights

Today, 10:44 PM

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.

AMCX

2 minute read

Earnings

Earnings Preview: ANI Pharmaceuticals

By Benzinga Insights

Today, 10:44 PM

On Friday, August 06, ANI Pharmaceuticals (NASDAQ:ANIP) will release its latest earnings report. Here is Benzinga's outlook for the company.

ANIP

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 10:44 PM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

1 minute read

ANI Pharmaceuticals Announces Refiling Of Cortrophin sNDA With FDA

By Bill Haddad

Today, 10:44 PM

ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ:ANIP) today announced that the Company has re-filed its supplemental new drug application ("sNDA") for Cortrophin® Gel

ANIP